Gene expression analysis of TFII-I modulated genes in mouse embryonic fibroblasts

Journal of Experimental Zoology Part B: Molecular and Developmental Evolution

Volumn 308, Issue 3, 2007, Pages 225-235

  Chimge, Nyam Osor ^a   Mungunsukh, Ognoon ^a   Ruddle, Frank ^a   Bayarsaihan, Dashzeveg ^b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR II;

ANIMAL; ARTICLE; CYTOLOGY; DNA MICROARRAY; EMBRYO (ANATOMY); FIBROBLAST; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS, TFII;

EID: 34249776665     PISSN: 15525007     EISSN: 15525015     Source Type: Journal    
DOI: 10.1002/jez.b.21134     Document Type: Article

References (45)

1. Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G. 2005. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121:645-657.
2. Bayarsaihan D, Ruddle FH. 2000. Isolation and characterization of BEN, a member of the TFII-I family of DNA-binding proteins containing distinct helix-loop-helix domains. Proc Natl Acad Sci USA 97:7342-7347.
3. Bayarsaihan D, Bitchevaia N, Enkhmandakh B, Tussie-Luna MI, Leckman JF, Roy A, Ruddle F. 2003. Expression of BEN, a member of TFII-I family of transcription factors, during mouse pre- and postimplantation development. Gene Express Patterns 3:579-589.
4. Bermingham JR, Jr., Shumas S, Whisenhunt T, Sirkowski EE, O'Connell S, Scherer SS, Rosenfeld MG. 2002. Identification of genes that are downregulated in the absence of the POU domain transcription factor pou3f1 (Oct-6, Tst-1, SCIP) in sciatic nerve. J Neurosci 22:10217-10231.
5. Chen J, Malcolm T, Estable MC, Roeder RG, Sadowski I. 2005. TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF. J Virol 79:4396-4406.
6. Cheriyath V, Roy AL. 2000. Alternatively spliced isoforms of TFII-I. Complex formation, nuclear translocation, and differential gene regulation. J Biol Chem 275:26300-26308.
7. Cheriyath V, Roy AL. 2001. Structure-function analysis of TFII-I. Roles of the N-terminal end, basic region, and I-repeats. J Biol Chem 276:8377-8383.
8. Cheriyath V, Novina CD, Roy AL. 1998. TFII-I regulates Vbeta promoter activity through an initiator element. Mol Cell Biol 18:4444-4454.
9. Depew MJ, Simpson CA, Morasso M, Rubenstein JL. 2005. Reassessing the Dlx code: the genetic regulation of branchial arch skeletal pattern and development. J Anat 207: 501-561.
10. Desgranges ZP, Ahn J, Lazebnik MB, Ashworth T, Lee C, Pestell RC, Rosenberg N, Prives C, Roy AL. 2005. Inhibition of TFII-I-dependent cell cycle regulation by p53. Mol Cell Biol 25:10940-10952.
11. Enkhmandakh B, Bitchevaia N, Ruddle F, Bayarsaihan D. 2004. The early embryonic expression of TFII-I during mouse preimplantation development. Gene Express Patterns 4:25-28.
12. Failli V, Rogard M, Mattei MG, Vernier P, Retaux S. 2000. Lhx9 and Lhx9alpha LIM-homeodomain factors: genomic structure, expression patterns, chromosomal localization, and phylogenetic analysis. Genomics 64:307-317.
13. Grueneberg DA, Henry RW, Brauer A, Novina CD, Cheriyath V, Roy AL, Gilman M. 1997. A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: identity to TFII-I. Genes Dev 11:2482-2493.
14. Hirota H, Matsuoka R, Chen XN, Salandanan LS, Lincoln A, Rose FE, Sunahara M, Osawa M, Bellugi U, Korenberg JR. 2003. Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23. Genet Med 5:311-321.
15. Hong M, Lin MY, Huang JM, Baumeister P, Hakre S, Roy AL, Lee AS. 2005. Transcriptional regulation of the Grp78 promoter by endoplasmic reticulum stress: role of TFII-I and its tyrosine phosphorylation. J Biol Chem 280: 16821-16828.
16. Hoppe R, Frank H, Breer H, Strotmann J. 2003. The clustered olfactory receptor gene family 262: genomic organization, promotor elements, and interacting transcription factors. Genome Res 13:2674-2685.
17. Jackson TA, Taylor HE, Sharma D, Desiderio S, Danoff SK. 2005. Vascular endothelial growth factor receptor-2: Counter-regulation by the transcription factors, TFII-I and TFII-IRD1. J Biol Chem 280:29856-29863.
18. Kim DW, Cheriyath V, Roy AL, Cochran BH. 1998. TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. Mol Cell Biol 18:3310-3320.
19. Ku M, Sokol SY, Wu J, Tussie-Luna MI, Roy AL, Hata A. 2005. Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors. Mol Cell Biol 25:7144-7157.
20. Lei H, Wang H, Juan AH, Ruddle FH. 2005. The identification of Hoxc8 target genes. Proc Natl Acad Sci USA 102: 2420-2424.
21. Manzano-Winkler B, Novina CD, Roy AL. 1996. TFII is required for transcription of the naturally TATA-less but initiator-containing Vbeta promoter. J Biol Chem 271: 12076-12081.
22. Medina-Martinez, O, Ramirez-Solis R. 2003. In vivo mutagenesis of the Hoxb8 hexapeptide domain leads to dominant homeotic transformations that mimic the loss-of-function mutations in genes of the Hoxb cluster. Dev Biol 264:77-90.
23. Montano MA, Kripke K, Norina CD, Achacoso P, Herzenberg LA, Roy AL, Nolan GP. 1996. NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I. Proc Natl Acad Sci USA 93:12376-12381.
24. Morris CA, Mervis CB, Hobart HH, Gregg RG, Bertrand J, Ensing GJ, Sommer A, Moore CA, Hopkin RJ, Spallone PA, Keating MT, Osborne L, Kimberley KW, Stock AD. 2003. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am J Med Genet A 123:45-59.
25. Nakagawa K, Yokosawa H. 2002. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett 530:204-208.
26. Novina CD, Cheriyath V, Roy AL. 1998. Regulation of TFII-I activity by phosphorylation. J Biol Chem 273:33443-33448.
27. Novina CD, Kumar S, Bajpai U, Cheriyath V, Zhang K, Pillai S, Wortis HH, Roy AL. 1999. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Mol Cell Biol 19:5014-5024.
28. O'Mahoney JV, Guven KL, Lin J, Joya JE, Robinson CS, Wade RP, Hardeman EC. 1998. Identification of a novel slow-muscle-fiber enhancer binding protein, MusTRD1. Mol Cell Biol 18:6641-6652.
29. Parker R, Phan T, Baumeister P, Roy B, Cheriyath V, Roy AL, Lee AS. 2001. Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: its autoregulation by stress and interaction with ATF6. Mol Cell Biol 21:3220-3233.
30. Perez Jurado LA, Wang YK, Peoples R, Coloma A, Cruces J, Francke U. 1998. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK. Hum Mol Genet 7:325-334.
31. Ring C, Ogata S, Meek L, Song J, Ohta T, Miyazono K, Cho KW. 2002. The role of a Williams-Beuren syndrome-associated helix-loop-helix domain-containing transcription factor in activin/nodal signaling. Genes Dev 16:820-835.
32. Roy AL. 2001. Biochemistry and biology of the inducible multifunctional transcription factor TFII-I. Gene 274: 1-13.
33. Roy AL, Meisterernst M, Pognonec P, Roeder RG. 1991. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354:245-248.
34. Roy AL, Carruthers C, Gutjahr T, Roeder RG. 1993. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 365:359-361.
35. Roy AL, Du H, Gregor PD, Novina CD, Martinez E, Roeder RG. 1997. Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J 16:7091-7104.
36. Stasyk T, Dubrovska A, Lomnytska M, Yakymovych I, Wernstedt C, Heldin CH, Hellman U, Souchelnytskyi S. 2005. Phosphoproteome profiling of transforming growth factor (TGF)-beta signaling: abrogation of TGFbeta1-dependent phosphorylation of transcription factor-II-I (TFII-I) enhances cooperation of TFII-I and Smad3 in transcription. Mol Biol Cell 16:4765-4780.
37. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623-655.
38. Tantin D, Tussie-Luna MI, Roy AL, Sharp PA. 2004. Regulation of immunoglobulin promoter activity by TFII-I class transcription factors. J Biol Chem 279:5460-5469.
39. Tissir F, Bar I, Goffinet AM, Lambert De Rouvroit C. 2002. Expression of the ankyrin repeat domain 6 gene (Ankrd6) during mouse brain development. Dev Dyn 224:465-469.
40. Tussie-Luna MI, Bayarsaihan D, Ruddle FH, Roy AL. 2001. Repression of TFII-I-dependent transcription by nuclear exclusion. Proc Natl Acad Sci USA 98:7789-7794.
41. Tussie-Luna MI, Bayarsaihan D, Seto E, Ruddle FH, Roy AL. 2002a. Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta. Proc Natl Acad Sci USA 99:12807-12812.
42. Tussie-Luna MI, Michel B, Hakre S, Roy AL. 2002b. The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxbeta/Siz2 is a transcriptional cofactor for TFII-I. J Biol Chem 277:43185-43193.
43. Wu Y, Patterson C. 1999. The human KDR/flk-1 gene contains a functional initiator element that is bound and transactivated by TFII-I. J Biol Chem 274:3207-3214.
44. Yang W, Desiderio S. 1997. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc Natl Acad Sci USA 94:604-609.
45. Yun TJ, Bevan MJ. 2003. Notch-regulated ankyrin-repeat protein inhibits Notch1 signaling: multiple Notch1 signaling pathways involved in T cell development. J Immunol 170: 5834-5841.